Searched for
AUROBINDO PHARMA SALES TARGET
Carlsberg India IPO gets Sebi approval along with three other public offers. Check detailsIndia’s IPO pipeline expands as Sebi clears papers for Carlsberg India, Matangi Rubber, Ujin Pharma and TMC Transformer. The approvals come...- TVS Motor September sales rise 24% to 6.73 lakh unitsTVS Motor Company reported a 24% rise in sales, reaching 672,790 units in September 2026. Domestic two-wheeler sales grew by 17% while elec...
- Maruti Suzuki India total sales rise 24% to 2.36 lakh units in SeptemberMaruti Suzuki India Ltd has reported a 24.4 percent rise in total sales, reaching 236,013 units in September. Domestic passenger vehicle sa...
- Royal Enfield records 8% rise in total sales to 1,33,958 units in SeptemberRoyal Enfield recorded total sales of 1,33,958 motorcycles in September, marking an 8% increase from last year. Domestic sales increased by...
- Honda Motorcycle India vehicle sales rise 24% to 7.06 lakh units in SeptHonda Motorcycle & Scooter India reported vehicle sales of 7,06,266 units for September 2026. This reflects a 24 percent increase compared ...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Sale Deed vs Agreement of Sale: What’s the Difference and Which One Gives You Ownership?
- Hyundai Motor India records 'highest-ever' monthly sales in Sept at 77,916 unitsHyundai Motor India registered a total of 77,916 units sold in September 2026. This figure includes 57,166 units sold domestically, reflect...
- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
- Stocks in news: Infosys, HDFC Bank, Jio Financial, IRFC, NCC and Blue DartIndian equity benchmarks experienced a decline over two sessions due to profit booking and rising oil prices. The Nifty 50 index closed dow...
- ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...
- MTAR Tech among 4 stocks showing White Marubozu patternFour Nifty 500 stocks, including MTAR Technologies, Mankind Pharma, CMPDI, and PTC Industries, formed a White Marubozu bullish candlestick ...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- Sun Pharma plans $1 billion local debt sale for loan takeout, sources saySun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- NSE shares fall 2%, slip below IPO price, but analysts’ target prices go up to Rs 2,050. Time to buy?NSE slipped below their Rs 1,785 IPO price on Monday, taking its market capitalisation to Rs 4.36 lakh crore. Despite the decline, brokerag...
- From CRM to performance intelligence: The next edge in enterprise salesThe companies that keep growing are the ones whose teams work to one plan and link the skills they build to the results they want.
- Jagsonpal Pharma to acquire Group Pharma’s wellness portfolioJagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
Load More
